2022 ADA Updated Guidelines: Individualizing Care, New Screening Recommendations and Increasing Education

This transcript has been edited for clarity.

Today I'm going to talk about the ADA 2022 Standards of Care. I've been working on these guidelines for the past 3 years as part of the Professional Practice Committee, and I can tell you how hard we work on these. We review everything that's been published in the past year, and have various committees and subcommittees that go through all of the data and come up with our recommendations.

The changes never seem to be earth-shattering, although we do publish supplements during the year as updates are needed. At the end of the year, really what we're trying to do is cull together everything that we think people should be thinking about and offer a pathway to help people better manage their patients with diabetes.

Most people tend to start with section 9 because this is where we discuss the management of hyperglycemia in patients with type 2 diabetes. Our whole world has really changed in terms of how we manage people with type 2 diabetes because we have agents such as GLP-1 receptor agonists and SGLT2 inhibitors that do more than just lower glucose.

We know now that cardiologists and nephrologists are all part of our team in terms of prescribing these medications.